Glaucoma Cases Following SARS-CoV-2 Vaccination: A VAERS Database Analysis

Background: To counter the rapidly spreading severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), global vaccination efforts were initiated in December 2020. We assess the risk of glaucoma following SARS-CoV-2 vaccination and evaluate its onset interval and clinical presentations in patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Rohan Bir, Parmar, Uday Pratap Singh, Cho, Wonkyung, Ichhpujani, Parul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9610013/
https://www.ncbi.nlm.nih.gov/pubmed/36298495
http://dx.doi.org/10.3390/vaccines10101630

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9610013/
https://www.ncbi.nlm.nih.gov/pubmed/36298495
http://dx.doi.org/10.3390/vaccines10101630

Ejemplares similares